CASGEVY
NDC 51167-290, exagamglogene autotemcel, injection, suspension, from Vertex Pharmaceuticals Incorporated.
- Product NDC
- 51167-290
- Status
- Listed
- Labeler
- Vertex Pharmaceuticals Incorporated
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAVENOUS
- Product type
- CELLULAR THERAPY
- Marketing category
- BLA
- Application
- BLA125787
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51167-290 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EXAGAMGLOGENE AUTOTEMCEL13000000 1/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51167-290-09 | 51167029009 | 9 VIAL in 1 CARTON (51167-290-09) / 20 mL in 1 VIAL (51167-290-01) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 51167-290 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51167-290 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51167-290. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.